David A. Tulis, PhD - Publications

Affiliations: 
Physiology East Carolina University, Greenville, NC, United States 

39 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Williams MD, Bullock MT, Johnson SC, Holland NA, Vuncannon DM, Oswald JZ, Adderley SP, Tulis DA. Protease-Activated Receptor 2 Controls Vascular Smooth Muscle Cell Proliferation in Cyclic AMP-Dependent Protein Kinase/Mitogen-Activated Protein Kinase Kinase 1/2-Dependent Manner. Journal of Vascular Research. 60: 213-226. PMID 37778342 DOI: 10.1159/000532032  0.427
2023 Francisco JT, Holt AW, Bullock MT, Williams MD, Poovey CE, Holland NA, Brault JJ, Tulis DA. FoxO3 normalizes Smad3-induced arterial smooth muscle cell growth. Frontiers in Physiology. 14: 1136998. PMID 37693008 DOI: 10.3389/fphys.2023.1136998  0.381
2022 Williams MD, Bullock MT, Holland NA, Johnson SC, Vuncannon DM, Oswald JZ, Adderley SP, Tulis DA. Protease-Activated Receptor-2 Differentially Regulates Vascular Smooth Muscle Cell Proliferation in Cyclic AMP-Dependent Protein Kinase/Phosphoinositide 3-Kinase-Dependent Manner. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. PMID 35551775 DOI: 10.1096/fasebj.2022.36.S1.R3765  0.426
2020 Davis PR, Miller SG, Verhoeven NA, Morgan JS, Tulis DA, Witczak CA, Brault JJ. Increased AMP deaminase activity decreases ATP content and slows protein degradation in cultured skeletal muscle. Metabolism: Clinical and Experimental. 154257. PMID 32370945 DOI: 10.1016/J.Metabol.2020.154257  0.362
2018 Holland NA, Francisco JT, Johnson SC, Morgan JS, Dennis TJ, Gadireddy NR, Tulis DA. Cyclic Nucleotide-Directed Protein Kinases in Cardiovascular Inflammation and Growth. Journal of Cardiovascular Development and Disease. 5. PMID 29367584 DOI: 10.3390/Jcdd5010006  0.444
2017 Tulis DA. Novel protein kinase targets in vascular smooth muscle therapeutics. Current Opinion in Pharmacology. 33: 12-16. PMID 28388507 DOI: 10.1016/J.Coph.2017.03.003  0.493
2016 Holt AW, Howard WE, Ables ET, George SM, Kukoly CA, Rabidou JE, Francisco JT, Chukwu AN, Tulis DA. Making the cut: Innovative methods for optimizing perfusion-based migration assays. Cytometry. Part a : the Journal of the International Society For Analytical Cytology. PMID 27984679 DOI: 10.1002/Cyto.A.23033  0.356
2016 Holt AW, Martin DN, Shaver PR, Adderley SP, Stone JD, Joshi CN, Francisco JT, Lust RM, Weidner DA, Shewchuk BM, Tulis DA. Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation. Cellular Signalling. PMID 27302407 DOI: 10.1016/J.Cellsig.2016.06.012  0.676
2015 Stone JD, Holt AW, Vuncannon JR, Brault JJ, Tulis DA. AMP-activated protein kinase inhibits transforming growth factor-β-mediated vascular smooth muscle cell growth: implications for a Smad-3-dependent mechanism. American Journal of Physiology. Heart and Circulatory Physiology. 309: H1251-9. PMID 26276823 DOI: 10.1152/Ajpheart.00846.2014  0.635
2015 Adderley SP, Martin DN, Tulis DA. Exchange protein activated by cAMP (EPAC) controls migration of vascular smooth muscle cells in concentration- and timedependent manner Archives of Physiology. 2: 2. DOI: 10.7243/2055-0898-2-2  0.37
2013 Johnson TL, Tulis DA, Keeler BE, Virag JA, Lust RM, Clemens S. The dopamine D3 receptor knockout mouse mimics aging-related changes in autonomic function and cardiac fibrosis. Plos One. 8: e74116. PMID 24023697 DOI: 10.1371/Journal.Pone.0074116  0.487
2013 Holt AW, Tulis DA. Experimental Rat and Mouse Carotid Artery Surgery: Injury & Remodeling Studies. Isrn Minimally Invasive Surgery. 2013. PMID 23762781 DOI: 10.1155/2013/167407  0.404
2013 Stone JD, Narine A, Shaver PR, Fox JC, Vuncannon JR, Tulis DA. AMP-activated protein kinase inhibits vascular smooth muscle cell proliferation and migration and vascular remodeling following injury. American Journal of Physiology. Heart and Circulatory Physiology. 304: H369-81. PMID 23203966 DOI: 10.1152/Ajpheart.00446.2012  0.693
2012 Stone JD, Narine A, Tulis DA. Inhibition of vascular smooth muscle growth via signaling crosstalk between AMP-activated protein kinase and cAMP-dependent protein kinase. Frontiers in Physiology. 3: 409. PMID 23112775 DOI: 10.3389/Fphys.2012.00409  0.671
2012 Joshi CN, Martin DN, Shaver P, Madamanchi C, Muller-Borer BJ, Tulis DA. Control of vascular smooth muscle cell growth by connexin 43. Frontiers in Physiology. 3: 220. PMID 22737133 DOI: 10.3389/Fphys.2012.00220  0.52
2012 Peyton KJ, Shebib AR, Azam MA, Liu XM, Tulis DA, Durante W. Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration. Frontiers in Pharmacology. 3: 48. PMID 22470341 DOI: 10.3389/Fphar.2012.00048  0.513
2012 Adderley SP, Joshi CN, Martin DN, Tulis DA. Phosphodiesterases Regulate BAY 41-2272-Induced VASP Phosphorylation in Vascular Smooth Muscle Cells. Frontiers in Pharmacology. 3: 10. PMID 22347188 DOI: 10.3389/Fphar.2012.00010  0.513
2011 Joshi CN, Martin DN, Fox JC, Mendelev NN, Brown TA, Tulis DA. The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways. The Journal of Pharmacology and Experimental Therapeutics. 339: 394-402. PMID 21825001 DOI: 10.1124/Jpet.111.183400  0.543
2009 Keswani AN, Peyton KJ, Durante W, Schafer AI, Tulis DA. The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects. Journal of Cardiovascular Pharmacology and Therapeutics. 14: 116-24. PMID 19342499 DOI: 10.1177/1074248409333266  0.527
2009 Mendelev NN, Williams VS, Tulis DA. Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells. Journal of Cardiovascular Pharmacology. 53: 121-31. PMID 19188837 DOI: 10.1097/Fjc.0B013E31819715C4  0.559
2009 Peyton KJ, Ensenat D, Azam MA, Keswani AN, Kannan S, Liu XM, Wang H, Tulis DA, Durante W. Arginase promotes neointima formation in rat injured carotid arteries. Arteriosclerosis, Thrombosis, and Vascular Biology. 29: 488-94. PMID 19164802 DOI: 10.1161/Atvbaha.108.183392  0.498
2009 Liu XM, Peyton KJ, Mendelev NN, Wang H, Tulis DA, Durante W. YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells. Molecular Pharmacology. 75: 208-17. PMID 18923065 DOI: 10.1124/Mol.108.048314  0.447
2008 Tulis DA. Novel therapies for cyclic GMP control of vascular smooth muscle growth. American Journal of Therapeutics. 15: 551-64. PMID 19127140 DOI: 10.1097/Mjt.0B013E318140052F  0.48
2007 Tulis DA. Histological and morphometric analyses for rat carotid balloon injury model. Methods in Molecular Medicine. 139: 31-66. PMID 18287663 DOI: 10.1007/978-1-59745-571-8_2  0.435
2007 Tulis DA. Rat carotid artery balloon injury model. Methods in Molecular Medicine. 139: 1-30. PMID 18287662 DOI: 10.1007/978-1-59745-571-8_1  0.427
2007 Jackson EB, Mukhopadhyay S, Tulis DA. Pharmacologic modulators of soluble guanylate cyclase/cyclic guanosine monophosphate in the vascular system - from bench top to bedside. Current Vascular Pharmacology. 5: 1-14. PMID 17266609 DOI: 10.2174/157016107779317224  0.463
2006 Tulis DA. Methods for identifying cardiovascular agents: a review. Recent Patents On Cardiovascular Drug Discovery. 1: 47-56. PMID 18221073 DOI: 10.2174/157489006775244236  0.413
2006 Yang X, Thomas DP, Zhang X, Culver BW, Alexander BM, Murdoch WJ, Rao MN, Tulis DA, Ren J, Sreejayan N. Curcumin inhibits platelet-derived growth factor-stimulated vascular smooth muscle cell function and injury-induced neointima formation. Arteriosclerosis, Thrombosis, and Vascular Biology. 26: 85-90. PMID 16239599 DOI: 10.1161/01.Atv.0000191635.00744.B6  0.537
2005 Tulis DA, Keswani AN, Peyton KJ, Wang H, Schafer AI, Durante W. Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries. Cellular and Molecular Biology (Noisy-Le-Grand, France). 51: 441-6. PMID 16309565 DOI: 10.1170/T648  0.328
2005 Masters KS, Lipke EA, Rice EE, Liel MS, Myler HA, Zygourakis C, Tulis DA, West JL. Nitric oxide-generating hydrogels inhibit neointima formation. Journal of Biomaterials Science. Polymer Edition. 16: 659-72. PMID 16001723 DOI: 10.1163/1568562053783722  0.406
2005 Tulis D, Durante W, Schafer A. Nitric oxide-independent regulation of the vascular injury response Bmc Pharmacology. 5: S25. DOI: 10.1186/1471-2210-5-S1-S25  0.524
2004 Tulis DA. Salutary properties of YC-1 in the cardiovascular and hematological systems. Current Medicinal Chemistry. Cardiovascular and Hematological Agents. 2: 343-59. PMID 15320784 DOI: 10.2174/1568016043356200  0.461
2004 Durante W, Tulis DA, KeswaniI AN, Wang H, Peyton KJ. ARGINASE PROMOTES VASCULAR SMOOTH MUSCLE CELL PROLIFERATION AND NEOINTIMA FORMATION Cardiovascular Pathology. 13: 46. DOI: 10.1016/J.Carpath.2004.03.131  0.442
2003 Tulis DA, Mnjoyan ZH, Schiesser RL, Shelat HS, Evans AJ, Zoldhelyi P, Fujise K. Adenoviral gene transfer of fortilin attenuates neointima formation through suppression of vascular smooth muscle cell proliferation and migration. Circulation. 107: 98-105. PMID 12515750 DOI: 10.1161/01.Cir.0000047675.86603.Eb  0.403
2002 Yuan Y, Liao L, Tulis DA, Xu J. Steroid receptor coactivator-3 is required for inhibition of neointima formation by estrogen. Circulation. 105: 2653-9. PMID 12045172 DOI: 10.1161/01.Cir.0000018947.95555.65  0.465
2002 Tulis DA, Bohl Masters KS, Lipke EA, Schiesser RL, Evans AJ, Peyton KJ, Durante W, West JL, Schafer AI. YC-1-mediated vascular protection through inhibition of smooth muscle cell proliferation and platelet function. Biochemical and Biophysical Research Communications. 291: 1014-21. PMID 11866467 DOI: 10.1006/Bbrc.2002.6552  0.482
2001 Tulis DA, Durante W, Liu X, Evans AJ, Peyton KJ, Schafer AI. Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation. Circulation. 104: 2710-5. PMID 11723024 DOI: 10.1161/Hc4701.099585  0.391
2001 Tulis DA, Durante W, Peyton KJ, Evans AJ, Schafer AI. Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries. Atherosclerosis. 155: 113-22. PMID 11223432 DOI: 10.1016/S0021-9150(00)00552-9  0.377
2000 Tulis DA, Durante W, Peyton KJ, Chapman GB, Evans AJ, Schafer AI. YC-1, a benzyl indazole derivative, stimulates vascular cGMP and inhibits neointima formation. Biochemical and Biophysical Research Communications. 279: 646-52. PMID 11118339 DOI: 10.1006/Bbrc.2000.3942  0.424
Show low-probability matches.